Here's Won't Touch Teva: Why I Pass on the Generic Giant
Teva Pharmaceuticals sits at a crossroads of debt, generics, and a shifting pricing landscape. Here's why I won't tou...
Find out various quick methods to raise money for bills. From side gigs to selling items, discover options that can help you financially.
20,495 articlesTeva Pharmaceuticals sits at a crossroads of debt, generics, and a shifting pricing landscape. Here's why I won't tou...
Geopolitical tensions trigger a broad 18% intraday volatility spike in the Nasdaq Composite, rattling tech names and ...
BUG, the Global X Cybersecurity ETF, underperformed as cybersecurity spending grew and tech markets shifted. The cont...
Broadcom is signaling strong momentum in AI infrastructure with a growing portfolio of custom chips and a robust back...
XRP has stabilized near $1.30, with a supply wall and on-chain behavior buffering downside. The piece breaks down wha...
A fresh federal study reveals stubbornly low starting salaries for graduates in critical fields. Here’s what it means...
Tech giants HPE, Oracle, and Adobe are set to report earnings next week, each carrying a distinct story on integratio...
Boards are rethinking CEO selection, prioritizing agility and AI fluency over years on the job. The shift could upend...
Autonomous AI agents are moving beyond chatbots to do complex tasks. This article explains why the agentic market cou...
NVIDIA unveils a major push into AI infrastructure, backing key optics and photonics partners to speed AI inference. ...
AI has redefined market leadership, with Nvidia at the center. But a looming $630 billion warning asks investors to s...
Nvidia has committed $2 billion to Nebius Group, accelerating Nebius’s role in the neocloud era. The move includes ea...